Triumeq Administration: Forms, Potencies, Methods, and Additional Information
In the treatment of HIV, one of the brand-name drugs commonly used is Triumeq. This medication, a combination of abacavir, dolutegravir, and lamivudine, is approved for use in adults and some children. However, the dosage can vary depending on factors such as age and weight.
For children aged 12 years or older who weigh at least 40 kg, the typical dosage of the Triumeq oral tablet is one combined tablet (50 mg dolutegravir, 600 mg abacavir, 300 mg lamivudine) taken once daily. Unfortunately, children weighing less than 40 kg should not take the Triumeq tablet, as the fixed-dose combination cannot be adjusted for lower body weights. In such cases, the doctor may prescribe the individual components separately.
Regarding the Triumeq PD oral suspension, specific weight-based dosing for children under 40 kg is not detailed explicitly. This oral suspension formulation is typically used for pediatric patients who cannot swallow tablets or require a dose adjusted by weight. However, the exact dosing guidelines would come from the product’s full prescribing information, usually involving mg/kg-based calculations.
For precise dosing of the oral suspension in children under 40 kg, it is recommended to refer to the full prescribing information or consult a healthcare provider. It is advisable to use individualized dosing guided by a specialist in pediatric HIV treatment.
It is essential to always follow the dosage that your doctor prescribes for you. If you take more than the recommended amount of Triumeq, call your doctor right away or contact America's Poison Centers at 800-222-1222.
Triumeq and Triumeq PD can be taken with or without food. If you miss a dose, take it as soon as you remember, but do not take two doses at once. Both Triumeq oral tablets and Triumeq PD oral suspension tablets should be swallowed whole without crushing, chewing, or cutting.
Triumeq PD tablets for oral suspension must be dissolved in water before swallowing. Neither Triumeq nor Triumeq PD are available in a generic version.
In summary, the dosage of Triumeq is determined based on body weight for children, with specific dosages provided in a table. For adults, the typical dosage is one tablet taken once per day. Abacavir and lamivudine in Triumeq are nucleoside reverse transcriptase inhibitors (NRTIs), while dolutegravir is an integrase inhibitor. Triumeq and Triumeq PD are meant to be used as long-term treatments.
